AbbVie's blood cancer therapy lowers disease progression, death risk in trial - Reuters
AbbVie's blood cancer therapy lowers disease progression, death risk in trial Reuters
🎗️
Онкология
🎗️Лента новостей
🎗️
Онкология
GenBio Inc. Introduces ProlifR™ as Development Identity for Emerging Oncology Research Program - The National Law Review
GenBio Inc. Introduces ProlifR™ as Development Identity for Emerging Oncology Research Program The National Law Review
🎗️
Онкология
AbbVie’s blood cancer therapy meets late-stage trial goals - WDEZ
AbbVie’s blood cancer therapy meets late-stage trial goals WDEZ
Онкология
Daraxonrasib ‘encouraging’ in RAS-mutant metastatic lung cancer
An oral drug widely expected to transform pancreatic cancer treatment has demonstrated encouraging clinical activity in metastatic non-small cell lung cancer. Daraxonrasib (Rasonque, Revolution Medicines) induced durable responses in patients with previously treated, RAS-mutant NSCLC, according to results of a phase…
Онкология
More Than a Pink Ribbon: What Breast Cancer Awareness Month Really Means for Black Women - Black Health Matters
More Than a Pink Ribbon: What Breast Cancer Awareness Month Really Means for Black Women Black Health Matters
Онкология
Lurie Children’s Launches First-in-Kids Clinical Trial of Innovative Radiation Therapy for Brain Tumors That Spares Healthy Tissue | Newswise - Newswise
Lurie Children’s Launches First-in-Kids Clinical Trial of Innovative Radiation Therapy for Brain Tumors That Spares Healthy Tissue | Newswise Newswise
Онкология
Известная российская телеведущая победила рак - Рамблер
Известная российская телеведущая победила рак Рамблер
Онкология
AbbVie’s blood cancer therapy meets late-stage trial goals - srnnews.com
AbbVie’s blood cancer therapy meets late-stage trial goals srnnews.com
Онкология
When Bone-Only HR+/HER2− Breast Cancer Turns Visceral: What PR Expression May Tell Us in the CDK4/6 Era - Oncodaily
When Bone-Only HR+/HER2− Breast Cancer Turns Visceral: What PR Expression May Tell Us in the CDK4/6 Era Oncodaily
Онкология
В России начали производить 5 препаратов для лечения рака
В России начали производить 5 препаратов для лечения рака lifehacker.ru
Онкология
UT Health Sciences Lands First K12 Training Grant to Build Pipeline for Cancer Researchers - UTHSC News
UT Health Sciences Lands First K12 Training Grant to Build Pipeline for Cancer Researchers UTHSC News
Онкология
В России начали производить 5 препаратов для лечения рака - Лайфхакер
В России начали производить 5 препаратов для лечения рака Лайфхакер
Онкология
Мария Машкова впервые призналась, что перенесла рак щитовидной железы - Кино Mail
Мария Машкова впервые призналась, что перенесла рак щитовидной железы Кино Mail
Онкология
Dr Vineet Talwar takes charge as Medical Director of Rajiv Gandhi Cancer Institute & Research Centre - BioSpectrum India
Dr Vineet Talwar takes charge as Medical Director of Rajiv Gandhi Cancer Institute & Research Centre BioSpectrum India
Онкология
Dr Vineet Talwar takes charge as Medical Director of Rajiv Gandhi Cancer Institute & Research Centre - BioSpectrum India
Dr Vineet Talwar takes charge as Medical Director of Rajiv Gandhi Cancer Institute & Research Centre BioSpectrum India